Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012–2018
Journal of Women's Health · 2024
DOI: 10.1089/jwh.2023.0643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Women's Health, 2024. Verfasst von Kyle J Moon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Health Outcomes and Policy Evaluation Studies, Ohio State University College of Public Health, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Insurance, Health, Reimbursement, Long-Acting Reversible Contraception, Medicaid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Background
To address reimbursement challenges associated with long-acting reversible contraception (LARC) in the postpartum period, state Medicaid programs have provided additional payments ("carve-outs"). Implementation has been heterogeneous, with states providing separate payments for the device only, procedure only, or both the device and procedure.
Methods
Claims data were drawn from 210,994 deliveries in the United States between 2012 and 2018. Using generalized estimating equations, we assess the relationship between Medicaid carve-out policies and the likelihood of LARC placement at (1) 3 days postpartum, (2) 60 days postpartum, and (3) 1 year postpartum, in Medicaid and commercially insured populations.
Results
Among Medicaid beneficiaries, the likelihood of receiving LARC was higher in states with any carve-out, compared with states without carve-outs, at 3 days (adjusted odds ratio [aOR] 1.49 [95% confidence interval: 1.33-1.67], p < 0.001), 60 days (aOR: 1.40 [95% CI: 1.35-1.46], p < 0.001), and 1 year postpartum (aOR: 1.15 [95% CI: 1.11-1.20], p < 0.001). Adjustments were made for geographic region, seasonality, and patient age. Heterogeneity was observed by carve-out type; device carve-outs were consistently associated with greater likelihood of postpartum LARC placement, compared with states with no carve-outs. Similar trends were observed among commercially insured patients.
Conclusion
Findings support the effectiveness of Medicaid carve-outs on postpartum LARC provision, particularly for device carve-outs, which were associated with increased postpartum LARC placement at 3 days, 60 days, and 1 year postpartum. This outcome suggests that policies to address cost-related barriers associated with LARC devices may prove most useful in overcoming barriers to immediate postpartum LARC placement, with the overarching aim of promoting reproductive autonomy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for Health Outcomes and Policy Evaluation Studies, Ohio State University College of Public Health, Columbus, Ohio, USA.
- Department of Economics, Lindner College of Business, University of Cincinnati, Cincinnati, Ohio, USA.
- Division of Epidemiology, Ohio State University College of Public Health, Columbus, Ohio, USA.
- Division of Infectious Diseases, Ohio State University College of Medicine, Columbus, Ohio, USA.
- Division of Health Services Management and Policy, Ohio State University College of Public Health, Columbus, Ohio, USA.
ORCID-Profile: Kyle J Moon
Zitieren
APA
Moon, K. J., Chang, L. V., Bryant, I., Hasenstab, K. A., Norris, A. H., & Nawaz, S. (2024). Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012–2018. Journal of Women's Health. https://doi.org/10.1089/jwh.2023.0643
Vancouver
Moon KJ, Chang LV, Bryant I, Hasenstab KA, Norris AH, Nawaz S. Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012–2018. Journal of Women's Health. 2024. doi:10.1089/jwh.2023.0643
BibTeX
@article{Moon2024,
author = {Moon, Kyle J and Chang, Lenisa V and Bryant, Ian and Hasenstab, Kathryn A and Norris, Alison H and Nawaz, Saira},
title = {Association of Medicaid Reimbursement Policies with Provision of Long-Acting Reversible Contraception in the Postpartum Period, 2012–2018},
journal = {Journal of Women's Health},
year = {2024},
doi = {10.1089/jwh.2023.0643}
}
EUVIMED